CDC-998

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCDC-998

Drug Alias NameCDC-998

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCelgene Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelgene Corp

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A